GENTIAN Financials

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>GD</div>
GENT-ME -- Norway Stock  

NOK 57.00  3.00  5.56%

Understanding current and past GENTIAN DIAGNOSTIC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. Use fundamental data analysis to validate all available fundamentals of GENTIAN DIAGNOSTIC to find out if markets are today mispricing the company. We were able to collect and analyze data for twenty-six available reported financial drivers for GENTIAN DIAGNOSTIC, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all GENTIAN DIAGNOSTIC financials, including its shares owned by insiders, price to book, revenue, as well as the relationship between the shares owned by institutions and price to sales . Use GENTIAN DIAGNOSTIC to enhance returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of GENTIAN DIAGNOSTIC to be traded at 71.25 in 30 days.

Search Fundamentals

With this module, you can analyze GENTIAN financials for your investing period. You should be able to track the changes in GENTIAN DIAGNOSTIC individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chance of Financial Distress

GENTIAN DIAGNOSTIC has less than 36 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for GENTIAN DIAGNOSTIC stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info


Gentian Diagnostics AS researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, the United States. The company was founded in 2001 and is headquartered in Moss, Norway. GENTIAN DIAGNOSTIC is traded on Oslo Stock Exchange in Norway.
InstrumentNorway Stock View All
ExchangeOslo Stock Exchange
Business AddressBjornasveien 5
IndustryDiagnostics & Research
Phone47 99 33 99 05


GENTIAN Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining GENTIAN DIAGNOSTIC's current stock value. Our valuation model uses many indicators to compare GENTIAN DIAGNOSTIC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GENTIAN DIAGNOSTIC competition to find correlations between indicators driving GENTIAN DIAGNOSTIC's intrinsic value. More Info.
GENTIAN DIAGNOSTIC is rated as one of the top companies in current valuation category among related companies. It is one of the top stocks in cash per share category among related companies . The ratio of Current Valuation to Cash per Share for GENTIAN DIAGNOSTIC is about  60,791,587 


The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on GENTIAN DIAGNOSTIC correlated with the market. If Beta is less than 0 GENTIAN DIAGNOSTIC generally moves in the opposite direction as compared to the market. If GENTIAN DIAGNOSTIC Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GENTIAN DIAGNOSTIC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GENTIAN DIAGNOSTIC is generally in the same direction as the market. If Beta > 1 GENTIAN DIAGNOSTIC moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.


What exactly are GENTIAN DIAGNOSTIC Financials? Typically, a company's financial statements are the reports that show the financial position of the company. There are three primary documents that fall into the category of financial statements. These documents include GENTIAN DIAGNOSTIC income statement, its balance sheet, and the statement of cash flows. Potential GENTIAN DIAGNOSTIC investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although GENTIAN DIAGNOSTIC investors may use each financial statement separately, they are all related. The changes in GENTIAN DIAGNOSTIC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GENTIAN DIAGNOSTIC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

GENTIAN DIAGNOSTIC July 11, 2020 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of GENTIAN DIAGNOSTIC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GENTIAN DIAGNOSTIC. We use our internally-developed statistical techniques to arrive at the intrinsic value of GENTIAN DIAGNOSTIC based on widely used predictive technical indicators. In general, we focus on analyzing GENTIAN DIAGNOSTIC stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GENTIAN DIAGNOSTIC's daily price indicators and compare them against related drivers.
Downside Deviation2.77
Information Ratio0.1086
Maximum Drawdown17.13
Value At Risk(3.85)
Potential Upside5.97
Please check Risk vs Return Analysis. Please also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page